AeroVironment Announces Fiscal 2027 First Quarter Results

AeroVironment reported record fiscal Q1 2027 revenue of $480.5 million, up 6% year over year. Quarterly bookings reached $0.7 billion, producing a 1.4 book-to-bill ratio, while funded backlog rose 37% year over year to a record $1.5 billion. The results indicate sustained demand and improved revenue visibility for the defense technology company.

Analysis

AVAV’s setup is increasingly a backlog-conversion and execution story rather than a pure drone-demand trade. The relevant upside is operating leverage: if production throughput improves on larger programs, incremental revenue should convert at a higher gross-margin rate than the current top-line growth implies. The countervailing risk is that larger defense programs often carry integration, supplier qualification and fixed-cost absorption risk before margins scale; investors should not capitalize backlog at the same multiple as delivered, cash-generative revenue.

Near term, the likely stock reaction depends less on demand visibility than on whether management reaffirms full-year revenue, adjusted EBITDA and free-cash-flow conversion. A sustained premium valuation versus KTOS requires evidence that AVAV can turn its broader unmanned-systems portfolio into faster organic growth and margin expansion, rather than merely acquired scale. Over 1-3 months, contract awards, production-rate disclosures and any upward revision to funded backlog conversion timing are catalysts; a guide-down in gross margin or working-capital build would matter more than another bookings headline.

The non-obvious beneficiary of stronger AVAV program execution is the defense-electronics and autonomy supply chain, particularly LHX and RTX, where sensor, communications and mission-system content can rise with unmanned-platform deployment. Conversely, KTOS is the cleaner relative short if AVAV demonstrates that its platform breadth is translating into awards that shift the market toward integrated autonomous systems rather than lower-cost target-drone exposure. The contrarian view is that the market may be overpaying for geopolitical demand before procurement dollars become production revenue; defense appropriations timing and continuing-resolution risk can delay conversion by quarters without changing long-run demand.

Key Decisions for Investors

• Do not chase AVAV on the initial release; initiate or add only if full-year revenue and EBITDA guidance are maintained or raised and management shows stable-to-improving gross margin. Use a 1-3 month horizon into the next contract and guidance update; a cut to FY27 profitability or a material working-capital deterioration falsifies the thesis.
• Consider a 3-6 month relative-value position: long AVAV / short KTOS in equal dollar amounts if AVAV’s next update demonstrates accelerating organic delivery growth and margin expansion. The payoff is multiple dispersion from integrated autonomy exposure; exit if KTOS wins a major unmanned-program award or AVAV misses delivery timing.
• For defense exposure without single-name execution risk, maintain LHX or RTX as secondary beneficiaries of higher unmanned-system deployment, but size below AVAV because the revenue sensitivity is diluted. Reassess around U.S. appropriations and any continuing-resolution extension, which can defer program funding despite intact demand.
• Set an alert for a disconnect between backlog growth and operating cash flow over the next two quarters. If receivables, inventory or contract assets absorb cash materially faster than revenue, reduce AVAV exposure: this would indicate conversion friction rather than the operating leverage implied by demand visibility.